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According to annual national mortality statistics,
been a fall in the death rate

for pulmonary

tuberculosis,

there has
and a rise

#

in death rates
of these

for carcinoma of the lung and emphysema.^

trends

is uncertain.

actual nature of

They may reflect alterations in the

these diseases,

but

the trends may also be due

improved methods of prevention and therapy,
certification.

The cause

and/or changes in diagnostic

The purpose of this research was to explore

of these possibilities — the role of

to

the third

changes in diagnostic tactics.

The mortality data of vital statistics have traditionally been
used for assessing rates of disease,
complete;

a death certificate is prepared whenever someone dies.

the other hand,

the use of death

certificates

creates significant questions about
contents

because the data are epidemiologically

the

as a source of data

reliability of

the data.

The

of the certificates will be affected by the variability of

individual clinicians,

by variations

by changes in diagnostic standards.

2

in nomenclature and coding,

themselves

can affect

and

Although individual clinicians

may apply the same diagnostic standards differently,
standards

On

a change

in the

the rates of disease more profoundly

than any vicissitudes of the people who use the standards.
To analyze

these events,

this investigation was concerned with

the diagnostic criteria and rates of

occurrence of

three major pulmonary

■

2
diseases — tuberculosis,

cancer,

and emphysema — during a span of

40 years at the New Haven Hospital.

PROBLEMS

IN DIAGNOSTIC CRITERIA

A clinician’s diagnosis is based
and accurately identify

clinical signs

(1)

on his ability to recognize

and symptoms,

(2)

on para-

clinical aids — including x-ray and laboratory data — available at
the time of diagnosis,
of this information.
clinical phenomena,
diagnosis.

1.

(3)

on the standards used

for interpretation

Although a physician may precisely identify the
the latter factors may alter his accuracy in

The sections

paraclinical aids
occurred

and

that follow are devoted

to the refinements in

and the changes in diagnostic standards that have

for the three pulmonary diseases under survey.

Tuberculosis
Tuberculosis provides a classic example of

standards.

In 1920,

change in diagnostic

the official Diagnostic Standards of

the National

Tuberculosis Association contained a section itemizing "minimum
standards" for diagnosis of pulmonary tuberculosis in adults with
negative sputum:
1.

When constitutional signs and symptoms and definite

past history are absent

or nearly so,

there

should be

demanded definite signs in the lungs, including persistent
rales at one or both apices.
By "persistent" it is meant
that

the rales must be present after cough at two or more

examinations, the patient having been under observation
at least one month.
2.
In the presence of constitutional signs and symptoms
such as loss of weight and strength, etc.,...there should
be demanded some abnormality in the lungs, but not
necessarily rales.
X-ray evidence of apical infiltration
may be of importance.

3
3.

Usually a process at the apices

should be considered

tuberculous and a process at the base to be nontuberculous until the contrary is proved, excepting
when a clear history of pleurisy is present.
4.

A hemorrhage

[defined elsewhere as "expectorated

blood, with or without sputum...when of one or

two

teaspoonsful"] is evidence of active pulmonary
tuberculosis until the contrary is proved.
[Publication
notes that "blood streaks, blood spots,
may not mean tuberculosis."]

etc., may or

5.
One should consider a typical pleurisy with
effusion as presumptive evidence of tuberculosis....

Later editions of

this publication illustrate the increasing specificity

of evidence demanded for diagnosis of this disease.

If sputa and

gastric washings

In 1940:

are carefully and

repeatedly examined,...negative

results are of

distinct diagnostic value.
It can be safely said,
that a patient with a demonstrable parenchymal
infiltration in the lung that is apparently active,
in whom tubercle bacilli cannot be demonstrated,
probably has a non-tuberculous lesion.4

In 1961:

The demonstration of tubercle bacilli in clinical
specimens is the one essential criterion in the
definite diagnosis of active tuberculosis.5

These different statements show a change in the demands for
demonstration of

the tubercle bacillus.

Moreover,

the diagnostic

criteria of 1920 would have permitted a designation of tuberculosis
to be given to many respiratory diseases that would receive other
diagnoses

today.

longer considered
tuberculosis,

For example, hemoptysis,

i.e.,

"hemorrhage",

is no

to be presumptive evidence of active pulmonary

but may be a symptom of many other diseases,

bronchogenic carcinoma.

including

The more extensive modern availability and

4
use of radiographic techniques,

cytologic and histologic evaluation,

and other laboratory methods have helped
clinical picture and

traverse the gap between the

the morphologic nature of disease,

and

thereby

increase accuracy in diagnosis.

_2.

Carcinoma of

the Lung

Ever since 1887, when Hampeln reported establishing the diagnosis
of primary carcinoma of the lung in a patient
diagnosis was verified post-mortem,

five months before

the

the importance of microscopic

diagnosis of the disease has been frequently investigated and verified.
In 1935,

Dudgeon and Wrigley,

malignant cells
larynx.

8

using a wet

film method,

demonstrated

in the sputa of patients with carcinoma of the lung or

In 1946,

Papanicolaou applied his smear technique to sputa,

9

and the value of cytodiagnosis was verified soon after in controlled

_ ,.

studies.

10

Cytologic and roentgenologic methods complement each other in
the diagnosis of lung cancer.

A carcinoma less

than one centimeter

in diameter cannot be visualized with standard x-ray methods. -^Although
"...there is no characteristic roentgenographic picture of carcinoma
of

the lung which clearly distinguishes it invariably from other

pulmonary lesions,"
silent lesions and,
lesions.

13

12

radiography often discovers peripheral clinically

in general,

provides precise localization of

Cytology is of particular value in diagnosis of centrally

located lesions,

which are often hidden on x-ray by hilar shadows.

14

Histologic methods also aid in accurate diagnosis of pulmonary
disease.
1883,

Diagnostic lung puncture was

first reported by Leyden in

after he used this technique to obtain bacteriologic diagnosis

6,

7

5
from a pneumonic lung.^"*

Martin and Ellis

to diagnosis of neoplastic disease.^

later applied the procedure

Since

the development of

alternative methods of obtaining histologic specimens,

such as

bronchoscopy and

scalene node biopsy,"^ needle biopsy is much less

frequently used,

but is still advocated

for "undiagnosed pleural

effusions and peripheral bronchogenic tumors

fixed

to or invading the

chest wall."^
Medical science has thus progressed to
procedures are available

to help determine

the point where many

the presence of lung cancer.

But there is at present no one procedure which can be satisfactorily
applied

to all cases of suspected carcinoma of

study may include bronchoscopy,
scalene node biopsy,
as to the diagnosis."

3.

bronchography,

the lung.

"A complete

exfoliative Cytology,

or early exploratory thoracotomy if doubt persists
19

Emphysema
Unlike demonstration of the tubercle bacillus

or the malignant cell in carcinoma of
is available

in tuberculosis

the lung, no single

criterion

to assure accurate clinical diagnosis for emphysema.

Emphysema itself is defined in morphologic terms

20

yet,

in most cases,

the clinician must rely on radiographic examination and pulmonary
function tests

as

guides

to the presence of

this morphologic entity.

The ambiguity of the clinical diagnosis of emphysema is
illustrated by differing viewpoints about which radiologic
including depression and flattening of diaphragms,
costophrenic angles,
chest cage,

blunting of

irregular radiolucency of lung fields,

overinflation,

findings —

enlarged

and abnormal retrosternal space — best

-

6
correlate with the anatomic findings.
statement on diagnostic standards,

21-23

According to one official

"except when bullae are present,

roentgenologic examination cannot reliably distinguish between
pulmonary emphysema and overinflation due to other causes."
manifestations of emphysema vary,
with no abnormal physical signs,

yet have morphologic evidence of

20

a reasonably good correlation has been found between

pulmonary structure and function,

and pulmonary

been useful for diagnostic purposes.
which definitively determines

24

function

tests have

There is no single

the presence of emphysema;

certain ventilatory measurements,
per unit of time

Clinical

and some patients may be asymptomatic

emphysema upon examination of their lungs.
In general,

20

function

however,

including forced expiratory volume

(usually FEV^ sec.),

forced expiratory flow

previously called maximum expiratory flow rate,

MEFR),

(^12^200-1200’

and pulmonary

nitrogen washout curves correlate best with the presence of,disease.
Measurements of vital capacity and diffusing capacity are not
reliable.

25—28

as

Although the presence of airway obstruction generally

correlates well with the presence of emphysema at necropsy,

and although

emphysema is usually associated with reduction in expiratory air flow,
airway obstruction may exist without emphysema.

26

’

27

’

29

Thus,

emphysema today remains a presumptive and recently popularized
diagnosis,

but it

"...should only be applied

in the observer's opinion,

2

to those cases in which,

the defined morbid anatomical changes of

emphysema can confidently be asserted to be present."

30

AAA

From these statements,
standards

for tuberculosis,

clinical

one can anticipate

carcinoma of

that diagnostic

the lung,

and emphysema

7
would be different today from what they were at various times in the
past.

This study seeks to determine how different these standards

have been, and how these differences have been applied in the
evaluation of patients.
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MATERIALS AND METHODS
A.

CLINICAL MATERIAL
The study

Haven Hospital,

initially included all patients discharged
during 1921,

pulmonary tuberculosis,
1921 was

1941,

from New

and 1961, with the diagnosis of

carcinoma of the lung,

chosen for survey because it was

the

or emphysema.

The year

first year for which a

cross-index system based on discharge diagnoses was established at
the hospital;

1941 was selected because it occurred 20 years later

while still preceding the advent of antibiotic

therapy;

1961 was

chosen because it marked the end of another twenty-year period,

and

because antibiotics were then available.
A search through the

cross-index files of the hospital

revealed 648 patients discharged during the survey years with
appropriate diagnoses.

the

The details of the solicited and acquired

case records are presented in Table 1.
Of these 648 cases,
1941,

and 21 records

four records

from 1921,

11 records

from

from 1961 could not be located by the record

room

staff despite repeated searches between June 1967 and April 1968.
Other case records were,
for the

after review,

excluded from further analysis

following reasons:
1.

Several charts had apparently been cross-indexed incorrectly

in the diagnostic file,

and contained either no mention of hospital

discharge during the survey years,

or

the patient was discharged after

hospital admission for an illness unrelated to those under survey.
case from 1921,

43 cases

from 1941,

and 14 cases

from 1961 were excluded

on this basis.
2.

One

Several patients with tuberculosis or carcinoma were

9
excluded because of uncertain diagnoses in which the disease was
specified only as probable or suspected:
tuberculosis were 12

in 1921,

cases of questionable
3.
excluded.
trauma,

the

forms of

emphysema were

one case of subcutaneous emphysema following

one case of

obstructive atelectasis,

compensatory emphysema secondary to
1961;

and two cases of "emphysema" in

1961.

The remaining 519 cases defined

JJ.

and six in 1961;

two in 1941 and seven in 1961.

Several cases of inappropriate

1921;

newborns,

four in 1941,

cancer were

These were:

the cases of questionable

the study population.

EXTRACTION AND CODING
In each case record,

thoroughly reviewed.

the patient’s entire clinical course was

The review included all data obtained before

and during the patient's hospitalization for the year under survey.
The available diagnostic evidence was extracted on a special form
according to a set of criteria established for the extraction
(Appendix 1).
of any

An open-type form was used,

in order to avoid omission

clinical or ancillary paraclinical diagnostic evidence.

form used for the extraction of data is shown in Appendix 2.

The
Critical

diagnostic evidence obtained at any time before the survey admission,
or after it but during the same year, was

included and its source

specifically identified.
After all the records were extracted,
(Appendix 3)

criteria were established

for coding the extracted data onto eighty-column Hollerith

coding sheets.

All the extractions and coding were done and checked

by the author.

Hollerith

(IBM)

cards were then punched according to

.

*
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the code,

and the punched cards were

then verified.

verifying were done by two different people.
data was

then spot-checked by the author.

The punching and

A print-out of

according to

described in the next section.

In addition

to analysis of data available to establish diagnosis

of these three pulmonary diseases,
index year,

of the

a tabulation was made,

for each

total number of hospital admissions and

of admissions of other pulmonary diseases

latter included all

C.

the cases cited in the

the number

that might present a clinical

picture similar to those of the three diseases under study.

diagnoses

coded

After these verifications,

the data were analyzed with an IBM Card Sorting Machine,
procedures

the

The

cross-index file of discharge

for a variety of pulmonary diseases

(listed in Table 4).

METHOD OF ANALYSIS
_1.

Consideration of Supportive Evidence
Each diagnosed disease was analyzed separately for each survey

year.

Certain data were regarded as supportive evidence of diagnosis.

When these

findings were present,

the evidence was marked "positive".

The criteria for positive supportive evidence in each disease were as
follows:

Tuberculosis;
a.

Clinical evidence - presence of symptoms and/or signs.
(1)

Symptoms - included pulmonic or infectious symptoms,
systemic symptoms.

(Pulmonic or infectious symptoms are

those indicated in coding criteria columns
Appendix 3.

16-19,

Systemic symptoms are anorexia,

and/or fatigability,

and/or

significant malaise,

21-23,

weakness

and weight loss

_

11
of
(2)

ten pounds

Signs signs

b.

or more.)

included intrapulmonic and/or extrapulmonic

(see coding criteria columns 26-33,

Demonstration of
secretions,

tubercle bacillus - in sputum,

gastric washings,

pleural fluid,

Appendix 3).
bronchial

swab of lesion

or biopsy specimen or histologic specimen itself.
c.

Positive

chest x-ray - included identification of lesion

and/or pleural effusion.
d.

Positive skin test.

Primary Carcinoma of
a.

Clinical evidence - presence of appropriate symptoms and/or
signs,

b.

as

for tuberculosis.

Positive histologic evidence - included bronchoscopic biopsy,
lymph node

(supraclavicular,

cervical),

aspiration biopsy of mediastinum, needle biopsy of

lung,
c.

the Lung:

axillary,

paratracheal,

or

or biopsy of lung or pericardium.

Positive

cytologic evidence - included sputum pap smear,

pleural fluid or bronchoscopic cytology.
d.

Positive chest x-ray -

included identification of lesion

and/or pleural effusion.

Emphysema:
a.

Clinical evidence - presence of

appropriate symptoms and/or

extrapulmonic signs.
(1)

Symptoms - as

for tuberculosis.

(2)

Extrapulmonic signs - included

clubbing of nails,

of accessory muscles of respiration,

cyanosis,

or

use

■
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increased A-P diameter of
b.

the chest.

Positive chest x-ray - included x-ray report with statement of
"emphysema" or "findings

consistent with emphysema" or "grossly

emphysematous configuration of

the lung fields" or "probable

emphysema" or mention of presence of bullae.
c.

Positive pulmonary function tests - at least "moderate"
dysfunction,

as indicated with standardized qualitative

description found in all cases in which complete pulmonary
function studies were done.

2_.

Criteria for

"Justified Diagnoses"

After analysis of
for diagnosis of

the

different supportive evidence available

these diseases,

"justified diagnosis".
whenever any one of

criteria were established for a

A diagnosis was considered to be "justified"

the conditions cited below was

fulfilled:

Pulmonary Tuberculosis:
a.

Positive x-ray and demonstration of tubercle bacillus;

or

b.

Demonstration of tubercle bacillus and positive skin test;

c.

Autopsy:

or

pulmonary tuberculosis — if patient died during
survey admission.

Primary Carcinoma of
a.

the Lung:

Positive x-ray and either histologic or cytologic evidence,
regardless of site;

b.

or

Negative x-ray and primary site evidence
Note:

Primary site = sputum cytology,
or cytology,

(histologic or cytologic).
bronchoscopic biopsy

or biopsy of lung or part,

needle biopsy.

including

13
Emphysema:
a.

Positive x-ray;

or

b.

Positive pulmonary function tests.

Although the criteria cited for a diagnosis of pulmonary
tuberculosis refer to active tuberculosis,
in most records whether

there was no clear indication

the diagnosis of "pulmonary tuberculosis"

referred to active or inactive disease.

Those cases considered

to

have "unjustified diagnoses" according to the above criteria were,
therefore,

divided into two groups:

active tuberculosis,
therapy.

and those who did not receive antituberculosis

For these purposes,

management"

"antituberculosis

consisted of any one of the

antituberculosis drug therapy;
advised;

those managed as if they had

patient

following procedures:
sent

recommendation of prolonged bed

employment in the country.

therapy" or "active

to sanatorium or sanatorium

rest at home or outdoor

Patients who had no "active management"

were further subdivided into cases in which the diagnosis of tuberculosis
was used

to explain the clinical picture,

and those in which it was not.

If the patient was not treated as though he had active
and if this diagnosis was not used

tuberculosis,

to explain the clinical picture,

diagnosis was removed from the final "unjustified" group.

his

The final

group of "unjustified diagnoses" of

tuberculosis

cases of

group who received antituberculosis

the original "unjustified"

thus included those

treatment or in whom the diagnosis of tuberculosis was used to explain
the clinical picture.

-<
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RESULTS
A.

TYPES _0F AVAILABLE EVIDENCE
The different evidence available at time of diagnosis of

tuberculosis,

primary carcinoma of the lung,

and emphysema is

summarized in Table 2.
Of particular note is

the frequency with which clinical evidence

alone was used to establish diagnosis of

tuberculosis and emphysema

in 1921,

and the increasing use of paraclinical evidence

In 1921,

40% of

tuberculosis

clinical evidence alone,
1941 and 1961.

diagnoses were made on the basis of

as compared with only 2% and 6% of

cases in

Although diagnosis of emphysema in a purely clinical

manner also declined

from 86% of cases in 1921 to 48% in 1941,

of diagnoses were still being made on this basis in 1961.
carcinoma of

thereafter.

36%

In contrast,

the lung was never diagnosed only with purely clinical

evidence during these years.
The data also indicate an increased use of chest x-ray
diagnosis of

tuberculosis

and emphysema since 1921.

for

Although 44% of

diagnosed cases of tuberculosis in 1921 apparently had no chest x-ray
taken,

roentgenographic examination was done in nearly all cases

the more recent years,

and

in

the percentage of patients with positive

x-rays also increased sharply.

Diagnosis of emphysema without

aid of x-ray also decreased after 1921,

the

although less dramatically

than for tuberculosis.

The

rate of positive x-rays in cases diagnosed

as emphysema also rose,

from 14% in 1921 to 52% in 1941,

but fell to

41% in 1961.
Carcinoma of

the lung was nearly always diagnosed after x-ray,

which was usually positive,

during all three years.

Cytologic and

15
histologic evidence have been used increasingly for
since

1941.

Forty-six per cent of cases during

this diagnosis

that year were

diagnosed from positive x-ray, without supplementary histologic or
cytologic verification;

only 7% of cases were

In diagnosis of tuberculosis,
bacillus

increased,

although

thus diagnosed in 1961.

demonstration of the

to only 53% of cases

incidence of administration of skin tests did not

tubercle

in 1961.

The

rise greatly,

the

rate of positive skin tests rose only 7% to 23%.

_B.

JUSTIFIED DIAGNOSES

and

According to the criteria given previously for justified
diagnosis of

tuberculosis,

carcinoma of

accuracy of their diagnosis has
(Table 3).

The

and emphysema,

increased during the survey period

frequency with which justified diagnoses of pulmonary

tuberculosis were made rose steadily,
50% in 1941 and 77% in 1961.
of

the lung,

the lung in 1921,

from 24% of cases in 1921 to

Excluding the single case of

carcinoma

which was apparently correctly diagnosed,

accuracy in diagnosis of that disease has also increased,
in 1941 to 94% in 1961.

In contrast,

from 64%

although the percentage of

justified diagnoses of emphysema rose from 14% in 1921 to 52% in 1941,
accuracy improved only slightly

to 57% in 1961.

stringent criteria are applied,

i.e.,

least moderate expiratory

resistance,

Indeed,

if more

bullae seen on x-ray and/or at
only 16% of diagnoses in 1961

were justified.

C.

OTHER PULMONARY DISEASES
Tabulation of

the number of admissions to the same hospital

16
during 1921,

1941,

and 1961 for diagnosed diseases that could present

overlapping clinical pictures is

given in Table

4.

In Table 5,

numbers are divided by the total number of hospital admissions
provide

Of interest is

the decreasing annual

incidence of

tuberculosis,

bronchitis and bronchiectasis,

and empyema,

and pleurisy,

as compared with the rise

of carcinoma of the lung,
pulmonary edema,

asthma,

and Hodgkin's

congestive heart

failure and

disease and lymphosarcoma.

and a later rise in 1961.

_

reports.

,

1

The

with a fall in

This change in the "hospitalization"

rate of emphysema is in marked contrast to its
as noted in the data of

lung abscess

in occurrence

diagnostic frequency of emphysema was highest in 1921,

rate,

to

the occurrence rates of hospitalization with respiratory

illnesses during each year.

1941,

these

rising annual

the United States Vital

"mortality"

Statistics

2

Of particular note is

the sharp decline after 1921 in total

incidence of hospitalizations with any form of

respiratory illness.

The rate in 1921 was 1697 per 10,000 admissions;
1941 is similar

to that in 1961.

the rate of 570 in
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DISCUSSION
These results demonstrate,

according to current standards,

accuracy in diagnosis of pulmonary tuberculosis,
the lung,

primary carcinoma of

and emphysema has increased significantly since 1921.

As exemplified by

tuberculosis,

changes

in diagnostic standards

have been a key factor in more accurate diagnosis.
the

that

Demonstration of

tubercle bacillus is crucial for diagnosis of active disease today,

but was not in 1921,

when clinical presumptive evidence alone was

considered sufficient

for diagnosis.

The same signs and symptoms

that

are now known to indicate the presence of one or more of several other
diseases,

could thus be considered diagnostic of tuberculosis in 1921.

Although a history of contact with active cases of
analyzed as a variable in

this study,

tuberculosis was not

it seems likely that

epidemiologic history was an important factor at

that

such an

time.

Advances in technology have helped produce more accurate diagnosis
and diagnostic standards.
have reduced

Increased reliance on cytology and histology

the instances in which carcinoma of the lung is diagnosed

by x-ray and clinical evidence alone.
procedures,

Use of multiple diagnostic

especially in cancer diagnosis,

has compensated

for the

relative insensitivity of an individual biopsy and/or cytology specimen.
The literature indicates the variability and unreliability of
clinical evidence and x-ray — except when bullae are identified — as
indicators of the presence of emphysema.

Pulmonary function tests are

recognized as a valuable adjunct in correlating pulmonary structure
and function in this disease.
only 20% of suspected cases.
incidence of diseases

Yet by 1961,

such tests were applied to

These data exemplify the way in which the

can "fluctuate with their fashions in clinical

18
diagnostic popularity."

Although official diagnostic standards have

been established to provide
presumptive

fairly good correlation between the

clinical diagnosis of emphysema and its morphologic

existence, many clinicians utilize
standards,

their own separate diagnostic

which rely on clinical evidence alone.
$

This study is
of diagnosed

limited by its approach.

tuberculosis,

lung cancer,

It considers only cases

and emphysema.

include all missed cases of these diseases.

It does not

The one reported case in

1921 of carcinoma of the lung would probably be considered the same
disease today.

It seems likely,

however,

disease were missed during that year,
were asymptomatic,

that other diagnoses of this

perhaps because the patients

or perhaps because they presented with clinical

pictures similar to other respiratory illnesses and were then misdiagnosed.
One can only guess
of tuberculosis,

as to what

the many "unjustified" diagnoses

carcinoma of the lung,

be called today.

and emphysema in the past would

It is important to realize that

the

changing

incidence rates of hospital diagnoses shown in Table 5 are distorted
to the extent

that hospitalizations during these different years were

the result of varied iatrotropic stimuli.

Thus, what brought people

to the hospital in 1921 may not have caused them to be hospitalized
in 1941 and 1961.
speculate as

Having noted

to the true nature

only at such examples as

these qualifications,

of misdiagnosed illnesses,

and wonder

the increasing annual incidence of asthma,

congestive heart failure and pulmonary edema,
pleurisy.

one can at best

and the decrease of

The marked decline after 1921 in incidence of hospitalization

for the cited respiratory diseases cannot be attributed to the advent
of antibiotics;

antibiotics were not yet available in 1941.

The

'
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decline may represent changes
admission policies,

in diagnostic standards,

altered hospital

or both.

This study is not intended to condemn past diagnosis with the
aid of a knowledgeable "retrospectoscope".

Clinicians of the past did

not have the paraclinical tests now available
evidence

into accurate diagnosis.

Indeed,

to help

convert bedside

forty years

from today,

when there may exist a more satisfactory way of diagnosing emphysema,
a reviewer of the

1968 diagnoses of this disease will probably pity the

poor clinician who had

to rely on presumptive clinical evidence for

diagnosis.
This study emphasizes the dangers of comparing the incidence
rates of chronic pulmonary disease — in particular
carcinoma of the lung,

and emphysema — diagnosed at different

and with different diagnostic standards.
substantial part of

tuberculosis,

The results suggest

the reported change in incidence of

may merely reflect a change in diagnostic standards.

/

times
that a

these diseases

1
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SUMMARY
This study explores the effects of changing criteria on the
diagnosis of pulmonary tuberculosis, carcinoma of the lung, and
emphysema during a span of 40 years at the New Haven Hospital.
The data available to establish diagnosis were analyzed for
519 cases discharged with one or more of these diagnoses in 1921,
1941,

or 1961.

The results indicate decreasing reliancfe on clinical

signs and symptoms alone to establish diagnosis of tuberculosis and
emphysema.

The diagnostic evidence was exclusively clinical for

tuberculosis in 40% of cases in 1921,

in 2% in 1941, and in 6% in 1961;

for emphysema, in 86% of cases in 1921, 48% in 1941, and 36% in 1961.
In contrast, cancer of the lung was usually diagnosed after positive
x-ray during all three survey years; however, 46% of diagnoses in 1941 were
made without supplementary histologic or cytologic verification, whereas
only 7% of cases were thus diagnosed in 1961.

For tuberculosis, the

tubercle bacillus was demonstrated with increasing frequency during the
survey period,

rising from 16% in 1921 to 53% of cases in 1961.

After analysis of the different supportive evidence available
for diagnosis of these diseases,
"justified diagnosis".
diagnosis has increased:

criteria were established for a

According to these criteria, accuracy in
for tuberculosis, from 24% of cases in 1921

to 50% in 1941, and 77% in 1961;

for carcinoma of the lung — excluding

the single "justified" case in 1921 — 64% in 1941, and 94% in 1961;
for emphysema,

14% in 1921, 52% in 1941, and 57% in 1961.

In order to obtain clues as to the true nature of these
"unjustified diagnoses" of tuberculosis,

cancer of the lung, and emphysema,

tabulation was made of the total hospitalizations and the number of

A
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admissions

to the same hospital with diagnosed illnesses

present a clinical picture similar to those of
o

The results of

,

this

_

that could

the diseases under study.

c

study thus suggest that a substantial

part of the reported change in incidence of pulmonary tuberculosis,
carcinoma of

the lung,

and emphysema may be a consequence of change

in diagnostic standards.

TABLE 1
CLINICAL MATERIAL

1921

1941

1961

65

146

91

3
12

3

2

No.

of cases listed
of cases missing
of cases excluded

21

10

no.

of cases

50

122

79

1

50

105

0

8

13

PULMONARY TUBERCULOSIS
No.
No.

studied

CARCINOMA OF THE LUNG
No. of cases listed
No.
No.
No.

of cases missing
of cases excluded
of cases studied

0
1(1° Ca)

18
24(22=1° Ca)

9
83(68=1°

(2=2° Ca)t

PULMONARY EMPHYSEMA
No. of cases listed
No.

of

No.
No.

of cases excluded
of cases studied

cases missing

(15=2°

17
1

36
0

125

2
14

10
26

11
108

6

CO-MORBIDITY*
Tuberculosis & Emphysema
Tuberculosis & Carcinoma
Emphysema & Carcinoma

TOTAL CASES

0
0
0

1
1(2° Ca)t
0

7
1(1°
2(1°

STUDIED
124
25

87

1

Emphysema

14

27

117

Total

65

Tuberculosis
Carcinoma of

50
the lung

174tt

86

ff

290tt

*A11 cases listed were studied.
tAfter record was obtained, these cases were discovered to have secondary
(metastatic) lung cancer and were excluded from further analysis.
t+Totals include multiple entries of cases with more than one of
under investigation.

the diseases

Ca)
Ca) t

TABLE 2
DIFFERENT EVIDENCE USED TO DIAGNOSE
TUBERCULOSIS,

CARCINOMA,

AND EMPHYSEMA

1921

1941

1961

TUBERCULOSIS
Total Cases

50

Clinical Evidence Only

20

(40%)

3

8

(16%)

52

(42%)

46

(53%)

Positive Chest X-ray

25

(50%)

118

(95%)

74

(85%)

Chest X-ray Not Done

22

(44%)

1

Positive Skin Test

8

(16%)

22

(18%)

20

(23%)

Skin Test Not Done

42

(84%)

94

(76%)

64

(74%)

AFB Shown During Life

87

124
(2%)

(1%)

5

3

(6%)

(3%)

PRIMARY LUNG CANCER
22

Total Cases

1

Clinical Evidence Only

0

(0%)

Positive Chest X-ray

1

(100%)

Chest X-ray Not Done

0

(0%)

Histologic Evidence

1

(100%)

Cytologic Evidence

0

(0%)

2

0

(0%)

10

Positive X-ray;

No Histologic

or Cytologic Evidence

0
21
0
11

71
(0%)
(95%)
(0%)

0
63
2

(0%)
(89%)
(3%)

(50%)

52

(73%)

(9%)

30

(42%)

(46%)

5

(7%)

EMPHYSEMA
Total Cases

14

Clinical Evidence Only

12

(86%)

13

(48%)

42

(36%)

Positive Chest X-ray

2

(14%)

14

(52%)

48

(41%)

Chest X-ray Not Done

5

(36%)

4

(15%)

7

(6%)

Bullae on X-ray

0

(0%)

0

(0%)

6

(5%)

0

(0%)

0

(0%)

34

(29%)

(100%)

94

(80%)

Abnormal Pulmonary Fen.
Pulm.

Fen.

Tests

Not Tested

Bullae + Abnormal Pulm.

14
Fen.

Bullae + Significant Expiratory
Resistance

117

27

(100%)

27

0

(0%)

0

(0%)

38

(32%)

0

(0%)

0

(0%)

19

(16%)

TABLE 3

OCCURRENCE RATES OF "JUSTIFIED1' DIAGNOSES

1921

PULMONARY TUBERCULOSIS*

PRIMARY CARCINOMA OF LUNG

PULMONARY EMPHYSEMA

12/50

1941

1961

62/124
(50%)

67/87
(77%)

1/1
(100%)

14/22

67/71

(64%)

(94%)

2/14

14/27
(52%)

67/117

(24%)

(14%)

(57%)

Numerators = number of cases with "justified" diagnoses,
Denominators = total number of cases with indicated diagnosis.

*According to modified diagnostic criteria cited in text.

TABLE 4
NUMBER OF HOSPITALIZATIONS WITH VARIOUS
RESPIRATORY ILLNESSES AT NEW HAVEN HOSPITAL

1921

1941

1961

9

246

548

14

169

203

1

2

1

16

41

66

18

62

20

12

25

25

Pneumothorax

6

10

35

As thma

0

0

99

0

5

41

0

10

11

0

0

1

1

21

154

50

124

87

1

25

86

14

27

117

DISEASE GROUP
Pneumonia,

Aspiration Pneumonia,

Bronchopneumonia
Bronchitis,

Bronchiectasis

Actinomycosis,

Hydatid Cyst,

Amebiasis,

Paragonimiasis,

Blastomycosis, Histoplasmosis,
Coccidioidomycosis
Pulmonary Infarction,
Embolism
Lung Abscess,
Pleurisy

Pulmonary

Empyema

(Nontuberculous)

Hodgkin's Disease,
Pneumoconioses,

Lymphosarcoma

Farmer's Lung

Pulmonary Sarcoidosis
Congestive Heart Failure,
Pulmonary Edema *
Pulmonary Tuberculosis
Carcinoma of Lung

(All Types)

Pulmonary Emphysema

TABLE 5
INCIDENCE RATES OF HOSPITALIZATION WITH
VARIOUS RESPIRATORY ILLNESSES AT NEW HAVEN HOSPITAL

TOTAL NUMBER OF HOSPITALIZATIONS
DISEASE GROUP
Pneumonia,

Aspiration Pneumonia,

Bronchiectasis

Actinomycosis, Hydatid Cyst,
Amebiasis, Paragonimiasis,
Blastomycosis, Histoplasmosis,
Coccidioidomycosis
Pulmonary Infarction,
Embolism
Lung Abscess,
Pleurisy

1941

1961

836

13,106

28,439

(Incidence/lO^ Adm.):

Bronchopneumonia
Bronchitis,

1921

Pulmonary

Empyema

(Nontuberculous)

Pneumothorax
As thma
Hodgkin's Disease,
Pneumoconioses,

Lymphosarcoma

Farmer's Lung

Pulmonary Sarcoidosis
Congestive Heart Failure,
Pulmonary Edema
Pulmonary Tuberculosis
Carcinoma of Lung

(All Types)

Pulmonary Emphysema
TOTAL INCIDENCE RATES OF ABOVE
RESPIRATORY ILLNESSES

RATES
108

188

193

167

12 9

72

12

2

<1

191

31

23

215

47

7

144

19

9

72

8

12

0

0

35

0

4

14

0

8

4

0

0

<1

12

16

54

597

95

31

12

19

30

167

20

41

1697

570

527

APPENDIX 1

Criteria for Extraction:

Age:

as

Diagnostic Evidence Study

recorded in admission note,

or by calculation from Date of Birth

& Zero Time.
Race:

as recorded in diagnostic sheet or adm.

note.

Year:

Index year.
If Zero Time occurred in previous year, put that year
in parenthesis.
Zero Time = date of first discharge at which the
target diagnosis was recorded.

Dx:

TBC,

EMPH,

or CA — or combinations.

Specify whether 1°

Ca lung or

2° Ca.
Iatrotropic Stimulus:
Use "—3>- "

Record only if it is not one of

to point

to the symptom(s),

the symptoms.

cited in the next section,

that acted as iatrotropic stimulus.
Symptoms:

Respiratory or allied complaints cited in "Present

or in progress notes.

Illness"

"Allied complaints" = fever, weight loss,

sweats, etc.
Severity of disease = total effect on patient’s
ability to work or to perform acts of daily life.
Signs:
RUL

Omit pulmonary findings except location.
(R.

upper lobe),

RLFP

appropriate

abbreviations.

fA-P diam.,

use of

Other:

Includes

Chest X-Ray:

(R.

lower field,

or other

[Keep track of abbreviations.]

access, muscles:

cyanosis,

Record location as
posteriorly)

Clubbing,

Record only if unequivocal.

etc.

Location of lesion:

use

lobes or fields

(e.g.,

RUL,

LLF),

or other designations as appropriate.
Cavity, abscess, empyema,
effusion:
Use
if equivocal (otherwise no symbol), and cite location.
Evidence

for TBC

Skin Test:

Circle

strength;
negative
for TBC:

the preparation

indicate results

(Tbcln or PPD)

as positive

( + ),

that was used;
equivocal

record

( @ ),

( - ), or not done ( ND ).
Sputum smear and sputum cultufe
record only the result, using symbols as above.
Gastric

washing:
is usually injected in a guinea pig.
Note if done other¬
wise, or if some other substance was injected in the guinea pig.
Other Skin Tests:
Record only the reaction as
ij ,
- ,
, or ND.
Note appropriately if some other test (e.g., complement fixation)
was used.
Sputum Pap Smear:

Record number positive per number done.

E.G.,

2/6

means 2 pos. and A neg. tests.
Use a middle section for equivocals,
e.g., 0/4/6 means 0 pos., A equivocal and 2 neg. tests.

-
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Bronchoscopy:

Record as ND,

2

Neg.,

(Cont'd)

-

or location of observed lesion.

(Don't describe lesion unless it was a mass;
Enter results,
or of biopsy.

if available,

if so,

of Bronchial washings

record "mass").
(for TBC or CA)

Pleural Fluid:
When available (otherwise "NA") ; describe as bloody,
serosanguinous,
amber, or purulent, according to gross description.
Record any pertinent smears, cytologic tests, or cultures.
"Pertinent" - in regard to TBC or CA.
Biopsy:
Record results of biopsy of any structure other than bronchus.
If not pos. for TBC, EMPH, or CA, record as
@
Resp.

Fen. Tests:
Record degree (slight, moderate, severe)
impairment for each of categories cited in chart:

of respiratory

Pulmonary distention
Pulmonary restriction
Impaired dynamic function
Impaired respiratory gas mixing
Impaired oxygenation
Venous admixture
Hyperventilation
Expiratory resistance
Disposition:
& INH.

Record anti-tuberculous Rx by name (not dose), e.g.. Strep.
If pt. had surgery, note what was done (e.g., R. upper

lobectomy)
(e.g.,

and the diagnostic finding in the removed specimen

TBC granuloma & pos.

AFB smear).

APPENDIX 2

DIAGNOSTIC EVIDENCE STUDY

Name

Iatro.

Age

Sex

Race

Year

Stim. :

Symptoms:

Chest X-ray
Location of Lesion:

Cavity:
Abscess:

Empyema:
Ef fusion:

Other:

Evidence for TBC
Skin Test Tbcln PPD:
Sputum Smear:
Sputum Culture:
Gastric Washing:
Other:

Severity of Disease

Other Skin Tests
Histoplasmin:
Coccidoidin:
Other:

Signs:

Dx

Location:
Sputum Pap Smear:

Clubbing:
Access.
Other:

IA-P diam:

Bronchoscopy:

Muscles:
Pleural Fluid:

Other:

Biopsy:

Smoking:
Resp.

Disposition

(Rx. ,

etc.)

Fen.

Tests:

'
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CODING CRITERIA
(For Hollerith Card)

(1),

(2),

(3):

CODING NUMBER

(4),

(5):
AGE
Years as of last birthday
00 = unknown
01 = one year or less

(6) :

(7) :

SEX AND RACE
1:
male, white
2:

male,

3:
4:

male, race unknown or other
female, white

Negro

5:
6:

female,
female,

Negro
race unknown

DIAGNOSIS
Tuberculosis

- 1

Emphysema
- 2
Carcinoma Lung - 4
(For combinations of above,

(8):

(9) :

add numbers.)

SURVEY YEAR
1:
2:

1941

1921

3:

1961

ZERO TIME
0:

same as survey year

1:

0-1 year preceding survey year

2:
3:

>1 year and <5 years preceding
>5 years and <10 years preceding

4:

>10 years preceding

5:
6:

"chronic"
unknown

(10) :

SOURCE OF DIAGNOSTIC EVIDENCE CITED
0:
1:

survey year admission only (or <2 weeks preceding admission)
survey year adm. + zero time

2:

survey year + within one year previous

3:

survey year + time between then and zero time

(hosp.

or clinic)

APPENDIX 3 (Cont'd)

-

2
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SMOKING STATUS AND HABITS
inapplicable or no mention of change in status
(11):
0:
stopped smoking before * event (* event = symptoms
1:

2:
3:
4:
5:
(12):

related to tbc., emph., or Ca.)
smoking before * event but continued smoking

changed
stopped
changed
stopped

smoking after onset of * event
smoking after * event but continued smoking ‘
smoking in past; when?

customary cigarettes

(13):

(most common mode prior to * event)

0:
1:

none or rare
<1/2 pack/day

2:

1/2

3:
4:

1
1-2

5:

2

6:

>2

7:

unknown

-

1

other tobacco habits
no mention of other habits

- 0

pipes

- 1

cigars

- 2

snuff or chewed

- 4

uses

(14):

tobacco but category unknown - 9

COMPLAINANT STATUS
0:

not applicable;

1:
2:

Complaints due to pulm. symptoms.
Pulm. symptoms; complaints due to other situation.
symptoms;

autopsy discovery

3:

Pulm.

4:
5:

No pulm. symptoms; complaints due to other situation.
Complaints of ? attribution.
(Pt. may or may not have

complaints due to these + other situation.

6:

Symptoms of

other symptoms attributed to lung.)
? attribution or

? existence;

complaints due

to other situation.
7:

(15):
0:

Complaints not

clearly determined.

IATROTROPIC STIMULUS
not applicable (0, 1,

7 above)

1:

Sx.

of other disease;

probably unrelated to T.E.C.

2:

Sx.

(tuberculosis, emphysema or carcinoma)
of other disease; relation to T.E.C. unclear.

3:
4:
5:

Sx. of other disease; probably related to T.E.C.
regular follow-up of a chest disease
abnormal finding on chest x-ray

■=
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SYMPTOMS
(16) :
DOE
- 1
PND or dyspnea - 2
orthopnea
- 4
(17) :

cough (not otherwise specified) - 1
cough, nonproductive
- 2
cough, productive
- 4

(18) :

gross hemoptysis
- 1
blood-streaked sputum - 2
foul-smelling sputum - 4

(19):

pleuritic chest pain
nonpleuritic chest pain
unknown re pleuritic character
"tightness", "pressure" or "vague ache" in chest

(20) :

anorexia
- 1
weakness and/or fatigability - 2
significant malaise
- 4

(21) :

night sweats
- 1
chills, fever or sweats - 2
cyanosis
- 4

(22) :

"chronic bronchitis" - 1
"asthma"
- 2
subjective wheezing - 4

(23) :

"URI" or "cold"
- 1
unresolving "pneumonia" - 2
"flu" or "grippe"
- 4

(24) :

hoarseness - 1
dysphagia - 2

(25) :

involuntary weight loss
0:
none or unk. (unknown)
1:
<10 lb.
2:
10-19 lb.
3:
20 lb.
4:
>20 lb.
7:
amount not indicated

-

1
2
4
5

'

*
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SIGNS
LOCATION
(26):
right side
0:
not applicable (lungs clear or no specified location)
1:
right lung, next digit = lobe
2:
right lung, next digit = field
3:
rales, wheezes or rhonchi - diffuse (next digit = 0)
4:
rales, wheezes or rhonchi - next digit = field
9:
no data-P.E. (+) at zero time or since (nexto 3 digits
(27):

)

lobe code
0:
not applicable or unk.
1:
upper
2:
middle
3:
upper and middle
4:
lower
5:
upper and lower
6:
middle and lower
7:
all 3 lobes

field code
0:
not applicable or unk.
1:
apex
2:
upper
3:
middle
4:
lower
5:
base
6:
apex and base

(28):

left side
0:
not applicable
1:
left lung, next digit = lobe
2:
left lung, next digit = field
3:
rales, wheezes or rhonchi - diffuse (next digit = 0)
4:
rales, wheezes or rhonchi - next digit = field

(29):

lobe code
0:
not applicable or unk.
1:
upper
2:
lower
3:
both lobes

(30) :

field code
0:
not applicable or unk.
1:
apex
2:
upper
3:
lower
4:
base
5:
apex and base

CLUBBING
ND (no data) - 0
(+)
- 1
(-) or (±)
- 2

(31) : accessory muscles - 1
cyanosis
- 2

(32):

A-P DIAMETER
ND or not increased
- 0
tA-P diameter or "barrel-shaped chest" - 1
"emphysematous chest"
- 2

APPENDIX 3
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(33);

LYMPHADENOPATHY
none or ND

- 0

axillary

- 1

cervical
- 2
supraclavicular - 4

CHEST X-RAY
LOCATION OF LESION
(34):

right side
0:
not applicable
1:

(no specified location)

right lung,

next digit = lobe

2:

right lung,

next digit =

3:
4:
8:

mediastinum only (next digit = 0)
No x-ray done this adm.; data from zero time or since
No x-ray done this adm.; x-ray at or since zero time,

9:

X-ray not done

reading unk.

(35):

(36):

(37):

field

(next five digits = 0)

(next five digits = 0)

lobe code

field code

0:

not applicable or unk.

0:

not applicable or unk.

1:

upper

1:

apex

2:

middle

3:

upper and middle

upper
middle
hilum or mediastinum

4:

lower

2:
3:
4:

5:
6:

upper and lower
middle and lower

5:
6:

lower
base

7:

all 3 lobes

7:

apex and hilum

*

left side
0:

not applicable

1:
2:

left lung, next digit = lobe
left lung, next digit = field

3:

mediastinum only

4:

no x-ray done this adm.;

data from zero time or since

lobe code
0:
not applicable or unk.

field code
0:
not applicable or unk.

1:

upper

1:

apex

2:
3:

lingula
upper and lingula

2:
3:

upper
middle

4:

lower

4:

hilum or mediastinum

5:
6:

upper and lower
lingula and lower

5:
6:

lower
base

7:
9:

all lobes
middle lobe

7:

apex and hilum

(anomalous)

APPENDIX 3
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(38):

(39):

-

cavity

- 1

abscess
empyema
primary Ghon focus (in cases not diagnosed as tbc.)
healed or fibrotic apical tbc. (in cases not dxed. as tbc.)

-

1:

right

2:
3:

left
both

as emphysema,

(inapplicable,

= 0, in all cases not diagnosed

unless "emphysema" is stated in x-ray)

0:

inapplicable

1:

X-ray not done.

(no dx.

of emph.

2:

X-ray negative for "emphysema"
conclusion thereof).

or no mention of emph.
(i.e.,

3:

X-ray positive for "emphysema".

6:

X-ray negative for "emphysema";

bronchogram done.

7:

X-ray positive for "emphysema";

bronchogram done.

9:

"Findings consistent with emphysema"
or "grossly emphysematous configuration of the

bullae

- 1

flattened diaphragms - 2
tA-P diameter
(42):

- 4

fibrosis
"chronic

- 1
lung disease" or

"chronic bronchopulmonary disease" - 2
"area of focal emphysema"

TUBERCULOSIS EVIDENCE
SKIN TEST
(43):

type
none indicated - 0
old tuberculin - 1
PPD
- 2
unk. type
- 4

(44):

PPD - test strength
0:

not applicable

1:
2:

not listed
1st

3:

intermediate

4:

2nd

in x-ray)

x-ray diagnosis or

or "probable emphysema"
(41):

2
4
8
9

effusion
0:
none or unk.

X-RAY EVIDENCE FOR EMPHYSEMA

(40):

6

(Cont'd)

- 4

lung fields"
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(45):

0. T. 0:
1:
2:
3:
4:
5:
6:
9:

test strength
not applicable
1/10 mg.
1/50
1/100
1/500
1/1000
1/10,000
unk.

(46):

reading (If positive - weakest dilution positive.
If negative only - strongest dilution negative.)
0: not applicable
1: (+) 48 hrs.
2: (-) 48 hrs.
3: (±) 48 hrs.
4: reading not recorded
5: (+) in past; ND this adm.
6: (-) in past; ND this adm.

SPUTUM
mode of collection
(47):
not done
unspecified Ad. Hoc.
24 hour
-

0
1
2
4

(48):

mode of concentration
unspecified
- 1
not concentrated (direct)
- 2
cone.
- 4
mode of collection unspecified; result = atypical AFB - 9
(Note:
09 implies ND this adm., atypical AFB at zero time)
[There was no occurrence of combinations of 9 with 1, 2 or 4]

(49):

result
0
1
2
3
4
5
6
7
8
9

not done or ND (no data)
0/1 tests positive
0/many
1/1
1/many
>l/many
results?
(+) in past; not done this adm.
(+) in past; (-) this adm.
(-) in past; not done this adm.
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0:
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GASTRIC WASHING
not done or ND

1:

inoculated

2:
3:
4:
5:
6:

inoculated into GP; results (-)
not specified re GP; results (+)
not specified re GP; results (-)
results?
(+) in past; not done this adm.

7:
9:

(+)
(-)

(51):

into guinea pig

(GP);

zero time or since; (-) this
in past; not done this adm.

BRONCHIAL SECRETIONS
0:
1:

ND
(+)

AFB

2:

(-)

AFB

5:
6:

results?
(+) in past;

not done this adm.

7:

(-)

not done this adm.

(52):
0

in past;

PLEURAL FLUID
ND

1
2

(+)

AFB

(-)

AFB

5
6

results ?
(+) in past;

not

7

(-)

not done this adm.

in past;

done this adm.

URINE

(53):
0

ND

1
2

(+)

5

results?

8

(-)
(+)

9

AFB

(-) AFB
in past;
in past;

not done this adm.
not done this adm.

STOOL

(54):
0

ND

1
2

(+) AFB
(-) AFB

5

results?
(-) in past;
(+) in past;

8
9

not done this adm.
not done this adm.

results

adm.

(+)

APPENDIX 3 (Cont'd)
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(55):
0:
1:
2:
5:

SWAB FROM LESION OR BIOPSY SPECIMEN
ND
(+) AFB
(-) AFB
results?

OTHER SKIN TESTS
(56):
0
1
2
5
6
7

HISTOPLASMIN
not done or ND
(+) 48 h rs.
(-) 48 hrs.
results ?
ND; (+) in pas t
ND; (-) in pas t

0:
1:
2:
5:
6:
7:

COCCIDIOIDIN
not done or ND
(+) 48 hrs.
(-) 48 hrs.
results ?
ND; (+) in past
ND; (-) in past

(57):

1581l BLASTOMYCIN
0
not done or ND
1
(+) 48 hrs.
2
(-) 48 hrs.
5
results?
6
ND; (+) in past
7
ND; (-) in past

(59):
0:
1:
2:
3:
4:
5:
7:
8:
9:

SPUTUM PAP SMEAR
not done or ND
none positive
none positive; at least one equivocal
only one positive
two or more positive
results?
(-) this adm. - (+) in past
ND this adm. - (+) in past
ND this adm. - (-) in past
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BRONCHOSCOPY
GROSS FINDINGS
(60):

location
ND or not done

- 0

trachea or carina
- 1
main stem bronchus - 2

(61):

other
negative

- 4
- 8

done,

- 9

results?

description
none or not applicable - 0
mass
bleeding or friable
other lesion

(62):

0

1

- 1
- 2
- 4

PATHOLOGIC FINDINGS
Test(s) done, none positive.

2

Positive biopsy and cytology.
Positive biopsy; cytology not positive, but done.

3

Positive biopsy;

4
5

Biopsy not done; cytology positive.
Biopsy not positive; cytology positive.

cytology not done.

7

No tests done or tests unsatisfactory.

8

Results unk.

9

Biopsy negative;
or

positive at

Biopsy not done;

zero time.

positive at

zero time

(if 60=0).

PLEURAL FLUID
(63) :

(64) :

gross description
0:

none noted or no thoracentesis performed

1:

"yellow", "straw-colored", "amber",
"normal" in appearance

2:

serosanguinous

3:

bloody

4:

purulent

7:

Specimen removed but not described.

cytology - cell block

"serous" or

(pleural fluid)

0:
1:
2:

none positive
none positive; at least one equivocal
only one positive

3:
7:

two or more positive
unk. or not done

APPENDIX 3 (Cont'd)
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BIOPSY
LOCATION
(65):
supraclavicular or scalene node - 1
2
axillary node
4
paratracheal node
aspiration biopsy - mediastinum - 9
(66):

(67)»

1
cervical node
2
pleura
lung or lobe (or part) - 4
pericardium
8
needle biopsy - lung
9

(68):
HISTOLOGY CODE
10:
epidermoid (squamous-cell) carcinoma
(Use if Ep. Ca. is not further specified.)
11:
highly differentiated; "well differentiated"
12:
mod. diff. or differentiated
13:
slightly differentiated; poorly diff.; mod. undifferentiated
14:
"anaplastic Ep. Ca."; pleomorphic epidermoid Ca.
15:
undifferentiated; dedifferentiated Ep. Ca.
19:
Biopsy not done this adm.; (+) for Ep. Ca. at zero time.
20:

small-cell carcinoma
21:
oval-cell structure ("oat cell Ca.")
22:
polygonal cell structure

30:

adenocarcinoma (mucinous adenocarcinoma)
31:
acinar; scirrhous adeno Ca.
32:
papillary (alveolar cell); bronchiolar Ca.
33:
chiefly "large cells"
34:
"anaplastic adeno Ca. "
35:
"undiff. adeno Ca."; "poorly diff. adeno Ca."
38:
adeno Ca. + bronchiolo-alveolar Ca.
39:
Biopsy not done this adm.; (+) for adeno Ca. at zero time.

40:

large-cell undifferentiated carcinoma
41:
giant-cell anaplastic
42:
pleomorphic
43:
plexiform

50:
51:
55:
56:
57:

combined epidermoid and adenocarcinoma
combined small-cell and adenocarcinoma
"anaplastic Ca."; poorly diff. Ca.; undiff. Ca.
"bronchogenic carcinoma"
"carcinoma" (type unspecified); malignant tumor cells
(type unspecified)
Biopsy not done this adm.; (+) for undiff. Ca. at zero time.

59:

,

'
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60:

cylindroid type
Biopsy not done this

70:

mesodermal tumor
71:
fibroma

76:
77:

cancer other than Ca.
"metastatic cancer"

72:

adm.;

cylindroid

type

(+) at

zero time

(type unspecified)

fibrosarcoma
lung

tuberculosis
81:
82:

90:

-

bronchial adenoma (type unspecified)
61:
carcinoid type
62:
69:

80:

12

tuberculoma
partial lobectomy in past

Biopsy neg.

for tbc.;

path.

unk.

for tbc.

PULMONARY FUNCTION STUDIES
not done or ND
(69):
slight resp.

impairment

(if no categories more than slight)

moderate resp. impairment (if no categories more than mod.)
marked resp. impairment (if only one function is» severe)
severe resp. impairment (if at least two parameters are severe)
abbreviated study - before thoracic surgery
(70):

expiratory resistance
0:
1:

ND or not done
none

2:
3:

slight
moderate

4:

severe

7:

present but to unknown degree

THERAPY
(71):

antineoplastic or antituberculous procedures
surgery to lung

- 1

radiation to lung - 2
cytotoxic agent
(72):

- 4

other therapy
none indicated - 0
INH
- 1

(73):

PAS

- 2

streptomycin

- 4

DISPOSITION
none indicated or "home" - 0
PMD
- 1
return to clinic
sanatorium

- 2
- 4

Pt.

- 9

died

APPENDIX 3 (Cont'd)
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(74):
0:

AUTOPSY
inapplicable - Pt.

alive at

discharge.

1:

Pt.

died.

Autopsy revealed no evidence of T.E.C.

2:
3:

Pt.
Pt.

died.
died.

Autopsy:
Autopsy:

4:
5:
6:

Pt. died.
Autopsy:
Autopsy:

7:
9:

Autopsy:
Ca. lung + emphysema
Pt. died - no autopsy or autopsy findings unk.

(75):

tuberculosis.
Ca. lung.

Autopsy:
emphysema.
tbc. + Ca. lung
tbc. + emphysema

If diagnosis is Ca.
inapplicable

lung:
- 0

primary Ca.
secondary Ca.

- primary known

secondary Ca.

- primary unk.

- 1
- 2
- 4

secondary Ca. - primary uncertain but
diagnosed primary Ca. elsewhere

there is
- 7

"probably primary"

(80):

- 9

SPECIAL COMMENTS
0:

negative cytology - bronchoscopy report:
"changes characteristic
of chronic emphysema" (Dx. apparently established with 1A-P
diameter, bronchoscopy report,
no mention of emphysema)
(+) for AFB

1:

CSF

2:

"lung puncture" - cytology negative

(+)

smoking history,

3:

thoracoscopy - negative

4:

intratracheal lipiodal with bronchography

5:
6:

diagnosis:
"peripheral primary Ca.
diagnosis = senile emphysema
CSF (-) for AFB

7:
8:

craniotomy done; biopsy:
metastatic Ep. Ca.
needle biopsy, ileum or ischium:
metastatic undiff.

9:

pulmonary function studies - ND this adm. ;
from previous adm.

x-ray -

RUL"

Ca.

_,

results in 69

_

70
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